Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | STAT3 | P40763 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | CHRNA7 | P36544 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.65 |
| ▸ | CES2 | O00748 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levomenol SCHEMBL12414344 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL24988 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL2728600 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL31157846 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL14515491 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Bisabolol SCHEMBL13220166 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL1245143 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL4259122 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL20838984 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL172398 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 37309 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746844-A1 | PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122075324-A | Moisturizing bath lotion for infants and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122075349-A | Formula and preparation process of efficient and stable natural sulfur hot spring bath concentrate | — | 2026-05-26 | — | — | CN | claimed |
| CN-122081184-A | Serratia marcescens for producing L-alpha-bisabolol and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026104595-A1 | USE OF A TETRAPEPTIDE OF FORMULA N-PALMITOYL-LYS-THR-PHE-LYS IN THE TREATMENT OF HUMAN ATOPIC DERMATITIS | LABOSPHERE (FR) | 2026-05-21 | — | — | WO | claimed |
| WO-2026104596-A1 | USE OF A TETRAPEPTIDE OF FORMULA N-PALMITOYL-LYS-THR-PHE-LYS IN THE TREATMENT OF NON-HUMAN ANIMAL ATOPIC DERMATITIS | EXTEMPOREL (FR) | 2026-05-21 | — | — | WO | claimed |
| EP-4743070-A1 | NOVEL INHIBITORS OF THYMIC STROMAL LYMPHOPOIETIN | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4743051-A1 | 3-HYDROXYPROPYLESTERS AS SOLUBILITY ENHANCERS FOR LIPOPHILIC INGREDIENTS | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4743059-A1 | TOPICAL ANTIOXIDANT COMPOSITIONS AND METHODS OF USING THE SAME | Alastin Skincare, Inc. (US) | 2026-05-20 | — | — | EP | claimed |
| US-4847071-A | SUNSCREEN AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1989-07-11 | — | — | US | claimed |
| US-4847069-A | SUNSCREEN AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1989-07-11 | — | — | US | claimed |
| US-4786497-A | EXTRACTION WITH LOWER ALCOHOL | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1988-11-22 | — | — | US | claimed |
| CN-85107994-A | Be rich in the preparation method of the storable extract of spring yellow chrysanthemum of active substance | — | 1987-05-06 | — | — | CN | claimed |
| CN-85108903-A | Method for producing a novel anti-inflammatory agent | — | 1986-06-10 | — | — | CN | claimed |
| US-4592911-A | Pressurization | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1986-06-03 | — | — | US | claimed |
| EP-0175185-A2 | Process for obtaining a preservable chamomile extract rich in active ingredients | ASTA Pharma Aktiengesellschaft (DE) | 1986-03-26 | — | — | EP | claimed |
| US-4545990-A | BENZOYL PEROXIDE AND COLLAGENIC PALMITOYL ACID, GLYCYRRHETINIC ACID, OR BISABOLOL, MERISTEM EXTRACT | L'OREAL (FR) | 1985-10-08 | — | — | US | claimed |
| EP-0100459-A2 | An aqueous liquid containing a fat-soluble substance | Eisai Co., Ltd. (JP) | 1984-02-15 | — | — | EP | claimed |
| US-3932533-A | TREATMENT WITH BASE | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1976-01-13 | — | — | US | claimed |